Philips Partners with LeQuest to Provide Online Interactive Training in Ultrasound

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and LeQuest, a leading provider of online interactive simulation-based training for the use of medical devices [1], today announced a partnership to provide online interactive training for the Philips Ultrasound Affiniti system. As a result, medical staff can train individually at their own convenience without the need for equipment, avoiding the resulting loss of operational time on the system, as well as supporting faster onboarding and increasing confidence through practice with realistic simulation scenarios. Healthcare providers benefit from improved workflow, operational efficiencies and better-trained staff.

The Affiniti system offers healthcare professionals a powerful combination of performance and workflow for quick and efficient diagnosis with low operating cost, providing exceptional image quality across applications such as radiology, obstetrics & gynecology, and cardiology. By providing a flexible training solution to healthcare providers, the partnership supports them to achieve key parts of the quadruple aim: an improved experience for staff and patients, better health outcomes and a lower cost of care.

"Partnering with LeQuest enables us to further expand our offering of solutions that aid in optimizing the healthcare ecosystem," said Bich Le, Senior Vice President and General Manager Ultrasound at Philips. "As the role of ultrasound continues to expand, new capabilities, such as remote clinical collaboration and virtual training, have been particularly valuable during the COVID-19 pandemic, enabling providers to reduce in-person contact and reduce infection risk."

"At LeQuest our goal is to improve the quality of care by unlocking the potential of both medical technology as well as the competence of medical staff to use devices to the limit of their possibilities," said Hicham Shatou, founder and CEO of LeQuest. "Our partnership with Philips is an important step on our path to achieving that ambition, extending the global reach of our capabilities and providing Philips ultrasound users with a hands-on experience of its Affiniti system in a virtual environment."

With the LeQuest training modules, users can master the system in an effective way, gain confidence by practicing with realistic simulation scenarios and learn and practice anytime, anywhere. Training modules are available for all models of the Affiniti system (Affiniti 30, 50, 70) with specific versions for each clinical segment (general imaging, obstetrics/gynecology, and cardiology). The LeQuest training modules for the Philips Ultrasound Affiniti system are currently available in LATAM, France, Benelux and Nordics and more countries will follow soon. For more information visit www.lequest.com/en/philips-affiniti.

The partnership with LeQuest adds to Philips' strong portfolio of Clinical Education Services in ultrasound. Helping to combat the COVID-19 pandemic, the company is also providing detailed, practical guidance to support clinicians using its ultrasound systems and software for patients affected by COVID-19. Through its Reacts collaborative platform, Philips is expanding its remote clinical collaboration and virtual training offerings across its portfolio.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

About LeQuest

LeQuest, founded in 2011 is a leading technology company focused on improving the quality of care by unlocking the potential of both medical technology as well as the competence of medical staff to use devices to the limit of their possibilities. We are developing online interactive simulation-based e- training for the use of medical devices. The LeQuest e-trainings accelerate the implementation of new medical equipment, close the consumption gap, and make users quickly gain confidence, knowledge and competence within a safe environment including certifying and re-certifying of the medical staff. LeQuest is a fast growing company. LeQuest was recently recognized as one of the 250 fastest-growing companies in the Netherlands for 2020.

1. Since 2017, Philips has owned a minority interest in LeQuest through its Philips Health Technology Venture Fund. For more information, please visit www.ventures.philips.com.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...